CClinicalTrials.gg
CompletedNCT07540169Updated Jul 7, 2026

The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer

An interventional study of A device/tool called a stress ball in Stomach Cancer, Chemotherapy-induced Nausea and Vomiting and Fatigue, sponsored by Yuzuncu Yil University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

In this study, we will observe the effects of the Stress Ball.

Read the detailed description

In this study and its process, we are investigating the effects of a stress ball on anxiety, nausea, and fatigue in patients undergoing chemotherapy and diagnosed with stomach cancer.

02

Conditions studied

  • Stomach Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Fatigue

Keywords

  • Stress Ball
03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's enrollment of 52 is below the median of 67 across 2,096 interventional studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 66 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between the ages of 18-80
  • Those who agree to participate in the study
  • Those without motor skill loss
  • Patients diagnosed with stomach cancer
  • Patients with hand-arm orientation skills

Exclusion criteria

Exclusion Criteria:

  • Patients with loss of motor skills
  • Patients who wish to withdraw from the study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Participants who were given a stress ball

    Device: A device/tool called a stress ball

  • No intervention
    Control Group

    Only the group being observed.

Interventions

  • DeviceA device/tool called a stress ball

    We are investigating what effects stress balls have on the aforementioned areas/personal experiences.

06

What researchers measure

Primary outcomes

  1. Anxiety

    Anxiety will be measured during chemotherapy.

    Time frame: up to 6 months

Secondary outcomes

  1. Nausea and fatigue

    Nausea and fatigue will be measured during chemotherapy.

    Time frame: up to 6 months

07

Study locations

2 sites
  • Institute of Health Sciences
    Van, Tuşba 65030, Turkey (Türkiye)
  • Van Yüzüncü Yıl University Institute of Health Sciences
    Van, Tuşba 65030, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07540169
Lead sponsor
Yuzuncu Yil University
Responsible party
Yavuz Uren (Asst. Prof., Yuzuncu Yil University) — Principal investigator
First posted
Apr 20, 2026
Start date
Mar 20, 2026
Primary completion
Jul 6, 2026
Completion
Jul 6, 2026
Last update
Jul 7, 2026

Study contacts

Yavuz Uren
study director · Van Yüzüncü Yıl University Institute of Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion